Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

169
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
169
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

471
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
471
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

145
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
145
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

124
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
124
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

852
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
852
Lipid Absorption01:24

Lipid Absorption

666
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
666

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of early serial serum NLRP3 measurements with 28-day mortality in sepsis: a single-center retrospective landmark cohort study.

BMC infectious diseases·2026
Same author

Maternal and Neonatal Perinatal Outcomes of Singleton Pregnancies in Advanced-Age Women Undergoing IVF/ICSI-ET Compared with Spontaneous Conception: A Retrospective Propensity Score Matched Cohort Study.

International journal of general medicine·2024
Same author

Analysis of fecal microbiota and related clinical indicators in ICU patients with sepsis.

Heliyon·2024
Same author

Sarcopenia negatively affects postoperative short-term outcomes of patients with non-cirrhosis liver cancer.

BMC cancer·2023
Same author

Maternal Serum tRNA-Derived Fragments (tRFs) as Potential Candidates for Diagnosis of Fetal Congenital Heart Disease.

Journal of cardiovascular development and disease·2023
Same author

Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study.

Clinical cancer research : an official journal of the American Association for Cancer Research·2023

Related Experiment Video

Updated: Sep 4, 2025

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
06:35

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice

Published on: June 28, 2021

4.2K

Blood Purification for Hypertriglyceridemia-Induced Acute Pancreatitis: A Meta-analysis.

Yaqiong Zhang1, Jueying Lin2, Lijun Wu3

  • 1From the Department of Gastroenterology and Oncology, Civil Aviation General Hospital, Beijing.

Pancreas
|July 20, 2022
PubMed
Summary

Blood purification (BP) therapy for acute pancreatitis caused by high triglycerides effectively lowers triglyceride levels and shortens hospital stays. However, it shows no significant difference in efficacy or mortality compared to conventional treatments.

More Related Videos

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
07:10

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct

Published on: April 1, 2022

4.4K
Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
07:38

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection

Published on: May 10, 2024

772

Related Experiment Videos

Last Updated: Sep 4, 2025

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
06:35

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice

Published on: June 28, 2021

4.2K
Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
07:10

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct

Published on: April 1, 2022

4.4K
Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
07:38

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection

Published on: May 10, 2024

772

Area of Science:

  • Medical research
  • Gastroenterology
  • Critical care medicine

Background:

  • Hypertriglyceridemia-induced acute pancreatitis is a severe condition requiring effective treatment.
  • Blood purification (BP) therapy is a potential intervention for managing this condition.
  • Evaluating the efficacy and safety of BP is crucial for clinical decision-making.

Purpose of the Study:

  • To investigate the efficacy and safety of blood purification (BP) therapy in patients with hypertriglyceridemia-induced acute pancreatitis.
  • To compare BP therapy with conventional treatment and insulin therapy.

Main Methods:

  • A systematic literature search was conducted across major databases (PubMed, Embase, Cochrane Library, Web of Science).
  • The meta-analysis included 13 studies involving 934 patients.
  • Patients were categorized into BP and control groups for analysis.

Main Results:

  • Blood purification therapy demonstrated a significant reduction in hospital stay compared to conventional treatment (MD, -4.96 days; P=0.01).
  • No significant differences were observed in overall efficacy or mortality between BP and control groups (P > 0.05).
  • Insulin therapy showed similar mortality to BP but resulted in fewer local complications and shorter hospital stays.

Conclusions:

  • Blood purification therapy effectively reduces triglyceride levels and shortens hospital stay in hypertriglyceridemia-induced acute pancreatitis.
  • BP therapy does not significantly improve overall efficacy or reduce mortality compared to conventional treatments.
  • Insulin therapy offers comparable outcomes to BP, with added benefits of reduced complications and lower costs.